Effect of Silibinin on Human Pancreatic Lipase Inhibition and Gut Microbiota in Healthy Volunteers: A Randomized Controlled Trial
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252312853 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Cristina Ponce Martínez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Investigación de Trastornos de la Alimentación, Facultad de Enfermería, Universidad Católica de Murcia, Campus de Guadalupe, Avda. de Los J…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Lipase, Silybin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SENECA Foundation, CIBEROBN, Institute of Health Carlos III.
Abstract (Originalsprache)
Thistle (Onopordum acanthium) has been traditionally employed for liver protection. However, we recently identified silibinin, the main bioactive compound of thistle extract, as an in vitro pancreatic lipase inhibitor, which suggested a potential role as an anti-obesity agent. This study aimed to assess, in vivo, the efficacy, safety, and effects of silibinin on human lipase. As a secondary objective, we evaluated potential changes in gut microbiota after silibinin treatment. A randomized trial comparing 150 mg/silibinin, 300 mg/silibinin, and a thistle extract (equivalent to 150 mg/silibinin) with placebo and orlistat/120 mg was conducted. Fecal fat excretion, clinical parameters, and microbiota changes were analyzed. Orlistat showed the highest fecal fat excretion, although thistle extract had similar results (p = 0.582). The 150 mg/silibinin group reported the fewest adverse effects. Both silibinin and orlistat reduced plasma triglycerides (p = 0.016) and waist circumference (p = 0.001). Specific microbiota changes, such as increases in Mycobacteriaceae and Veillonellaceae, were associated with higher fat excretion. Although the present work was conducted in the short term and in people of normal weight, our results suggest that silibinin may be safe and effective for obesity, with minimal adverse effects and no significant changes in microbiota diversity. Further studies are needed to explore its microbiota-related benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unidad de Investigación de Trastornos de la Alimentación, Facultad de Enfermería, Universidad Católica de Murcia, Campus de Guadalupe, Avda. de Los Jerónimos, s/n, 30107 Murcia, Spain.
- Bioinformatics and High Performance Computing Group, Universidad Católica de Murcia, Campus de Guadalupe, Avda. de Los Jerónimos, s/n, 30107 Murcia, Spain.
- Obesity, Diabetes and Metabolism Laboratory, Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain.
- Department of Nutrition, Food Sciences and Physiology, Center for Nutrition Research, Universidad de Navarra, C/Irunlarrea, 1, 31008 Pamplona, Spain.
- Navarra Institute for Health Research (IdiSNA), C/Irunlarrea, 3, 31008 Pamplona, Spain.
- Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, 28029 Madrid, Spain.
ORCID-Profile: Elena Murcia García, Horacio Pérez Sánchez, Fermín I Milagro, José I Riezu-Boj, Bruno Ramos Molina, María Gómez Gallego, Juan José Hernández Morante
Förderung
- SENECA Foundation
- CIBEROBN
- Institute of Health Carlos III
- SENECA Foundation of the Region of Murcia (Spain)
- “Miguel Servet” program from the Institute of Health Carlos III
- Fondo Europeo de Desarrollo Regional-FEDER
Zitieren
APA
Ponce Martínez, C., Murcia García, E., Pérez Sánchez, H., Milagro, F. I., Riezu-Boj, J. I., Ramos Molina, B., Gómez Gallego, M., Zamora, S., Cañavate Cutillas, R., & Hernández Morante, J. J. (2024). Effect of Silibinin on Human Pancreatic Lipase Inhibition and Gut Microbiota in Healthy Volunteers: A Randomized Controlled Trial. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312853
Vancouver
Ponce Martínez C, Murcia García E, Pérez Sánchez H, Milagro FI, Riezu-Boj JI, Ramos Molina B, et al. Effect of Silibinin on Human Pancreatic Lipase Inhibition and Gut Microbiota in Healthy Volunteers: A Randomized Controlled Trial. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312853
BibTeX
@article{PonceMartnez2024,
author = {Ponce Martínez, Cristina and Murcia García, Elena and Pérez Sánchez, Horacio and Milagro, Fermín I and Riezu-Boj, José I and Ramos Molina, Bruno and Gómez Gallego, María and Zamora, Salvador and Cañavate Cutillas, Rubén and Hernández Morante, Juan José},
title = {Effect of Silibinin on Human Pancreatic Lipase Inhibition and Gut Microbiota in Healthy Volunteers: A Randomized Controlled Trial},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252312853}
}
EUVIMED